Florida Public Health Review
Volume 7

Article 14

December 2010

Translating Hemoglobin A1c Scores across an Ethnically Diverse
Population: Is the Language Consistent across All Races?
Corliss M. Allen
Eartha S. Butler
Joseph Negusei
Celeste Hart
Ivette A. López

See next page for additional authors

Follow this and additional works at: https://digitalcommons.unf.edu/fphr
Part of the Public Health Commons, and the Social and Behavioral Sciences Commons

Recommended Citation
Allen, Corliss M.; Butler, Eartha S.; Negusei, Joseph; Hart, Celeste; López, Ivette A.; Harris, Cynthia M.; and
Ralston, Penny (2010) "Translating Hemoglobin A1c Scores across an Ethnically Diverse Population: Is
the Language Consistent across All Races?," Florida Public Health Review: Vol. 7, Article 14.
Available at: https://digitalcommons.unf.edu/fphr/vol7/iss1/14

This Research Brief is brought to you for free and open
access by the Brooks College of Health at UNF Digital
Commons. It has been accepted for inclusion in Florida
Public Health Review by an authorized administrator of
UNF Digital Commons. For more information, please
contact Digital Projects.
© December 2010 Protected by original copyright, with
some rights reserved.

Translating Hemoglobin A1c Scores across an Ethnically Diverse Population: Is
the Language Consistent across All Races?
Authors
Corliss M. Allen, Eartha S. Butler, Joseph Negusei, Celeste Hart, Ivette A. López, Cynthia M. Harris, and
Penny Ralston

This research brief is available in Florida Public Health Review: https://digitalcommons.unf.edu/fphr/vol7/iss1/14

Allen et al.: Translating Hemoglobin A1c Scores across an Ethnically Diverse Po

Translating Hemoglobin A1c Scores across
an Ethnically Diverse Population: Is the
Language Consistent across All Races?
Corliss M. Allen, MPH, Eartha S. Butler, MPH, Joseph Negusei, MPH, Celeste Hart, MD,
Ivette A. López, PhD, MPH, Cynthia M. Harris, PhD, DABT, Penny Ralston, PhD
ABSTRACT
Hemoglobin A1c testing is an accepted measure of how well the blood glucose level has been controlled in the
recent past (six to eight weeks) among individuals with diabetes. The purpose of this study was to evaluate the
relationship between hemoglobin A1c (HbA1c) and blood glucose in an ethnically diverse population in a clinical
setting. A cross-sectional research design was employed to explore associations between these two diabetes control
measures in a sample of African American, White and Hispanic patients receiving diabetes treatment and follow-up in an
outpatient clinic in Tallahassee, Florida. Data collection included a questionnaire, medical examinations, and lab results.
Although we found a significant association between the glucose level and the HbA1c levels, the A1c value did not predict
the mean glucose value as closely as previously found in less diverse groups. These findings suggest there is need for further
study of these two variables among minority groups.
Florida Public Health Review, 2010; 7, 101-105.
Background
Type 2 diabetes mellitus is a chronic disease that
progresses through a spectrum of impaired glucose
tolerance until fasting hyperglycemia (an abnormally
high blood sugar level) appears as the liver
production of glucose declines. A high quality of life
is possible for individuals with this disease, but longterm care to stave off complications and effectively
manage the disease is necessary. The landmark
Diabetes Control and Complications trial (DCCT,
1993) corroborated the glucose hypothesis (that there
is a correlation between diabetic complications and
hyperglycemia) and also established the hemoglobin
A1C test as the gold standard tool to gauge blood
glucose control in persons with diabetes for more
than a quarter of a century (Delameter, 2010). In the
DCCT, subjects were randomized into a conventional
therapy group or an intensive treatment group. The
latter maintained a lower blood glucose level during
the trial. As a result, the intensive treatment group
exhibited a significant reduction in prevalence of
retinopathy, renal disease and diabetic neuropathy
(DCCT, 1993).
Although the hemoglobin A1c test is broadly
accepted as the standard for assessing blood sugar
control in patients with diabetes, test results can be
impacted by a number of conditions independent of
blood glucose. Among these are renal failure,
anemia, certain drugs and hemoglobin variants.
Among variant hemoglobins known to distort the
Florida Public Health Review, 2010; 7:101-105.
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relationship between HbA1c and mean blood glucose
are hemoglobin S and C (Frank et al., 2000).
Hemoglobin variants are much more prevalent
among certain ethnic groups. Previous studies have
underscored discrepancies in the hemoglobin A1c of
minorities when compared to non-Hispanic whites.
In a meta-analysis describing disparities in
Hemoglobin A1c levels between African Americans
and non-Hispanic whites, a hemoglobin A1c
difference of approximately 0.65% was found among
African Americans (Kirk, 2006). A similar metaanalysis comparing A1c between Hispanics and nonHispanic whites discovered an A1c approximately
0.5% higher among Hispanics (Kirk, 2008).
Moreover, prior studies relating Hemoglobin A1C
and mean blood glucose have only included a limited
number of minority participants. In the DCCT, 96.5%
of the study participants were white, while 2% were
Black and 1.5 % ‘other’. In the Nathan (2005) study,
whites comprised 83.2% of subjects in the study
translating the A1c assay into estimated average
glucose values.
Other researchers have pointed out the
difficulties with the HbA1c indicator in minority
populations. In addition to biological factors, quality
of care and socioeconomic status were also suggested
factors driving the differences in HbA1c control
(Karter, 2002). Lack of access to health care and a
reduced frequency in obtaining preventive services
were also associated to the A1c disparities within
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minority groups (Rhee, 2005). Nevertheless, the
HbA1c test continues to serve as the most reliable
measurement of glycemic control, and large scale
trials have established the need for glycemic control
to temper diabetic complications (DCCT, 1993).
Approximately 7.6% of Leon County residents
were diagnosed with type 2 diabetes mellitus in 2007
(CDC, 2007). Non-Hispanic Blacks were 1.5 times
more likely to be diagnosed. Non-Hispanic Blacks
were 6 times more likely than other ethnic groups to
receive 10 or more A1c test in a 12-month period,
suggesting their diabetes is not controlled.
Methods
Data Collection Methods
This study evaluated the relationship between
hemoglobin A1c and blood glucose in an ethnically
diverse group in a clinical setting. For this purpose,
we assessed serial blood glucose monitoring data and
compared this to hemoglobin A1c values among
diabetic patients in an outpatient diabetes clinic in
Leon County, Florida. Blood sugar meter data,
downloaded electronically and stored in the
Electronic Medical Record (EMR) were used to
provide the glucose level indicator. Each patient was
assigned a confidential code number and from each
of their records several measures were collected,
including: (1) Date range; (2) Mean blood glucose
[MBG]; (3) Frequency of MBG recordings within
given date range; (4) Meter make and model; (5)
Hemoglobin A1c value; (6) Recorded date of A1c
value; and (7) Standard reference range.
Mean blood glucose and Hemoglobin A1c values
were examined to determine its variability when
compared to the standard established in previous
studies. Information was based on two different
records from the EMR database, at two distinct points
within a year to ensure consistency in our results.
Hypothesis
We hypothesized that there would be a
significant positive relationship between the glucose
level and the hemoglobin A1c level of patients with
type 2 diabetes. We focused on this variability
between the hemoglobin A1c and mean blood
glucose because it can lead to treatment errors and
poor patient compliance and adherence to prescribed
regimens of diet, exercise, and drug therapy.
Participants
The selection criteria for the study participants
included: (1) Diagnosis of type 2 diabetes mellitus;
(2) Continuous care at the clinic for a minimum of
three years; (3) Serum creatinine of 1.4 or below; (4)
Verification of non-gravid status for females of
childbearing age; and (5) Absence of severe co-
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morbidity that would be expected to impact
hemoglobin A1c. Patients who met these criteria
were identified by the clinic physician using an
electronic medical record (EMR) database. The final
study sample was composed by 28 participants:
38.5% African American, 60% White and 1.5 %
other patients. This research was approved by the
Institutional Review Board at Florida Agricultural
and Mechanical University [FAMU].
Data Analysis
Data were selected between April 2008 and
December 2008. A total of 48 patient records were
selected from the North Florida Regional Thyroid
Center. All analyses were conducted with SPSS 11.
Bivariate analyses focused on the association
between HbA1c and mean glucose levels, and
Pearson correlations were obtained for the variables
of interest. Multivariate analyses consisted of a
linear regression test used to compare the two
variables and describe their association.
Results
The final study sample consisted of 28 patients
after the selected criterion was applied. The records
were retrieved from March 2006 to July 2008, with
the majority of records (75%) from the year 2008.
Most of the patients used AccuChek (76%), whereas
the others used OneTouch (20%) and Bayer Ascenia
(3.3%). Although the majority of the sample
population was white (60%), there were nonHispanic blacks (38%) and other races (2%) as well.
As hypothesized, there was a significant
relationship between the glucose level and the A1c
level of type 2 diabetes patients. As the data in Table
1 show, there was a statistically significant, positive
association found between the variables of mean
glucose level and HbA1c (p = .01).
Bivariate Analyses
The actual average glucose for this sample was
174.96 (Figure 1). This mean corresponds to an
estimated A1c level of approximately 7.0. However,
the actual average A1c level for this sample was 8.07
(Figure 2). We found that the A1c value did not
predict the mean glucose value as closely as in less
diverse samples.
Multivariate Analyses
To explore the relationship between the mean
glucose and the average HbA1C levels further, a
linear regression was used to compare the two
variables (Figure 3). The line represents the normal
relationship between HbA1c levels and mean glucose
levels. The circular points provide a graphic
depiction of how distant from the norm (depicted by
the line of best fit) the levels of our sample were.
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Table 1. Correlation between Average Glucose and the Average A1c Score

Correlations

Average Mean

Average Mean

Average A1c Score

1.000

.489**

Pearson
Correlation
Sig. (2-tailed)

N
Average A1c Score Pearson

.010
28.000

27

.489**

1.000

Correlation
Sig. (2-tailed)

.010

N

27

28.000

**. Correlation is significant at the 0.01 level (2-tailed).

Figure 1. Average Glucose Level among
Study Participants

Florida Public Health Review, 2010; 7:101-105.
http://health.usf.edu/publichealth/fphr/index.htm
Published by UNF Digital Commons, 2010

103
3

Florida Public Health Review, Vol. 7 [2010], Art. 14

Figure 2. Average Hemoglobin A1c Level among
Study Participants

Figure 3. Linear Regression between Mean Glucose Level and Hemoglobin A1c Level

Our hypothesis was that there would be a
statistically significant, positive association between
mean glucose level and HbA1c. Although our null
hypothesis was rejected, the central theme of this
study was not just the positive association but that
such an association was not as strong in an ethnically
diverse population.
Discussion
The aim of this study was to evaluate the
relationship between Hemoglobin A1c and blood
Florida Public Health Review, 2010; 7:101-105.
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glucose in an ethnically diverse group in a clinical
setting. The average blood glucose and HbA1c data were
compared among diabetes patients at the North Florida
Regional Thyroid Center. As hypothesized, we found
that the relationship between HbA1c and the mean
blood glucose may vary more widely in an ethnically
diverse population. This variability may lead to treatment
errors and poor compliance. The study consisted 38.5%
of African Americans, 60% of Whites, and 1.5% of other
ethnicities with type 2 diabetes mellitus.
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Our study was guided by the landmark Diabetes
Control and Complication Trial (DCCT), published
in 1993, which assisted in validating the glucose
hypothesis. Whereas there was a correlation trend
between A1c and mean glucose in our ethnically
diverse sample, the strength of the association did not
appear as strong as in a non-ethnically diverse sample
(Nathan et al, 2005; DCCT, 1993). Our findings are
consonant with those by Kirk et al. (2006, 2008), and
reflect an imperative of diabetes inequity research
regarding the continued evaluation of standards.
Therefore, our findings suggest that the assumption
that standards such as HbA1c will act congruently
across populations should be reexamined.
The present study has notable limitations.
Principally, this study was limited by the small sample
size. In addition, not having identical systems to record
patient data such as Accuchek was another limitation.
Further, the recorded data we obtained did not contain
demographic data (such as gender, date of birth, or age).
Finally, we were unable to compare those individuals
who were cared for by a specialist to those who were not.
Despite these limitations, this study underscores
the need for additional exploration for possible
variability in standard A1c scores. Future studies that
focus on the equitable utility of the standards with a
larger sample, as well as on cofounding variables
such as SES, number of self testing per year, poor
compliance, physician-patient relationship and age
can have significant implications for selfmanagement and treatment regiments, especially for
minority populations.
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